Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
暂无分享,去创建一个
K. Anderson | N. Munshi | P. Richardson | D. Chauhan | Y. Tai | J. Jakubikova | G. Gorgun | D. Cirstea | N. Mimura | Y. Yoshida | F. Cottini | T. Utsugi | S. Kikuchi | R. Suzuki | H. Ohguchi | J. Minami | T. Hidehsima | K. Anderson